Form 8-K BRISTOL MYERS SQUIBB CO For: Jul 26

Go back to Form 8-K BRISTOL MYERS SQUIBB CO For: Jul 26

Bristol-Myers Squibb Co. (BMY) PT Raised to $57 at Goldman Sachs

July 29, 2024 7:18 AM EDT

Goldman Sachs analyst Chris Shibutani raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $57.00 (from $55.00) while maintaining a Buy rating.

The analyst comments "BMY's noteworthy outperformance on Friday July 26 (+~11% vs. flat XLV), while it occurred amidst favorable shifts in the broader market macro backdrop, was earned, in our... More